Home / Author Archives: Market Watch (page 3)

Author Archives: Market Watch

Blueprint Medicines shares gain on deal with Roche

Shares of Blueprint Medicines Corp. gained 8.3% in premarket trading on Tuesday, the day after the company announced a deal with Roche Holding AG to develop and commercialize pralsetinib, an investigational cancer drug. Roche will pay $775 million upfront in ...

Read More »